The median effective doses (ED50) of 28 lots of killed Pasteurella pestis strain 195/P vaccine were determined in mice and guinea pigs. Mice were injected with vaccine alone, whereas guinea pigs received vaccine suspended in incomplete Freund's adjuvant. Potency ratios of vaccines were obtained by comparing the ED50 of the test with that of a reference vaccine. Mean potency ratios of 1.82 + 0.50 in mice and 3.22 i 0.56 in guinea pigs were obtained, and the difference between these means was significant, P = <0.01. The number of organisms in the challenge dose did not significantly affect the ED50 of a vaccine in guinea pigs. However, irrespective of vaccinating route, nearly 1,000 times as much vaccine was required in the absence of adjuvant as in its presence to produce comparable protective indexes in the guinea pig. The response of guinea pigs did not offer any improvement over mice in evaluating the efficacy of plague vaccines.
This laboratory has evaluated commercially prepared vaccines for several years. In our efforts to improve the test, a comparison of immunity in guinea pigs and mice was conducted. The results from this study form the basis of this report.
Although it was thought (2) that killed plague bacilli were relatively nonimmunogenic in guinea pigs, Keppie, Cocking, and Smith (3) and subsequently Chen, Foster, and Meyer (1) showed that in fact guinea pigs could be immunized with various antigens of Pasteurella pestis as well as the whole organism. We comparedthe potencies of formaldehyde-killed whole organism plague vaccines in mice and guinea pigs by methods outlined by Chen, Foster, and Meyer (1).
MATERIALS AND METHODS
Vaccines. The plague vaccines were prepared by Cutter Laboratories as described by Chen et al. (1) . They consisted of different lots of formaldehydekilled suspensions of P. pestis strain 195/P containing 2 X 109 particles per ml, with phenol as preservative.
A lyophilized reference standard vaccine was supplied by the Division of Biologics Standards, National Institutes of Health, Bethesda, Md., and was stored at 4 C. Samples were resuspended in 0.85% sodium chloride (saline) solution for testing. Each A comparison (Table 2) of the results between mice and guinea pigs shows a probability of <0.01. The 28 vaccines were not tested in mice and guinea pigs at the same time. As will be shown, the use of adjuvant is responsible for the generally higher ED50 in guinea pigs.
Reproducibility. Inasmuch as vaccine lots were tested on different occasions, reproducibility was gauged by testing two vaccines three times, concomitantly in mice and guinea pigs. Table 3 shows potency ratios obtained in both species. The variation in mouse potency ratios was 2.5-fold for Response of guinea pigs to vaccine without adjuvant. As shown in Table 5 , animals receiving one or two intramuscular doses of plague vaccine without adjuvant required more than 1,000 times as much vaccine for protection as the animals receiving vaccine with adjuvant.
It was also possible to protect guinea pigs against low levels of challenge by giving one dose of vaccine without adjuvant by either the subcutaneous or intraperitoneal routes. The data in Table 6 show that similar protection against 88 P. pestis cells was obtained when either one or two doses of vaccine were injected. Even with higher challenge levels, the proportion of protected animals remained about the same. 
DISCUSSION

